chr10-25997137-TTA-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_017433.5(MYO3A):c.409-16_409-15delAT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0436 in 1,575,894 control chromosomes in the GnomAD database, including 1,752 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.043 ( 174 hom., cov: 32)
Exomes 𝑓: 0.044 ( 1578 hom. )
Consequence
MYO3A
NM_017433.5 intron
NM_017433.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.06
Genes affected
MYO3A (HGNC:7601): (myosin IIIA) The protein encoded by this gene belongs to the myosin superfamily. Myosins are actin-dependent motor proteins and are categorized into conventional myosins (class II) and unconventional myosins (classes I and III through XV) based on their variable C-terminal cargo-binding domains. Class III myosins, such as this one, have a kinase domain N-terminal to the conserved N-terminal motor domains and are expressed in photoreceptors. The protein encoded by this gene plays an important role in hearing in humans. Three different recessive, loss of function mutations in the encoded protein have been shown to cause nonsyndromic progressive hearing loss. Expression of this gene is highly restricted, with the strongest expression in retina and cochlea. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 10-25997137-TTA-T is Benign according to our data. Variant chr10-25997137-TTA-T is described in ClinVar as [Benign]. Clinvar id is 164604.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0602 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO3A | NM_017433.5 | c.409-16_409-15delAT | intron_variant | ENST00000642920.2 | NP_059129.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO3A | ENST00000642920.2 | c.409-16_409-15delAT | intron_variant | NM_017433.5 | ENSP00000495965.1 |
Frequencies
GnomAD3 genomes AF: 0.0428 AC: 6517AN: 152168Hom.: 173 Cov.: 32
GnomAD3 genomes
AF:
AC:
6517
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0405 AC: 10140AN: 250424Hom.: 252 AF XY: 0.0416 AC XY: 5628AN XY: 135358
GnomAD3 exomes
AF:
AC:
10140
AN:
250424
Hom.:
AF XY:
AC XY:
5628
AN XY:
135358
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0437 AC: 62170AN: 1423608Hom.: 1578 AF XY: 0.0438 AC XY: 31123AN XY: 710686
GnomAD4 exome
AF:
AC:
62170
AN:
1423608
Hom.:
AF XY:
AC XY:
31123
AN XY:
710686
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0428 AC: 6512AN: 152286Hom.: 174 Cov.: 32 AF XY: 0.0412 AC XY: 3069AN XY: 74472
GnomAD4 genome
AF:
AC:
6512
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
3069
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
59
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 13, 2013 | 409-16_409-15delAT in intron 5 of MYO3A: This variant is not expected to have cl inical significance because it has been identified in 5.3% (445/8242) of Europea n American chromosomes and 4.1% (176/4264) of African American chromosomes from a broad population by the NHLBI Exome sequencing project, and 3.1% (69/2178) of chromosomes from the 1000 Genome Project (http://evs.gs.washington.edu/EVS/; dbS NP rs139987960). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 11, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at